Study of perforations during clot removal for stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial looks at what happens when a hole (perforation) occurs in a brain artery during clot removal for stroke. It compares patients who had this complication to those who did not, to understand how to better manage it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older and had a clot-caused stroke (ischemic stroke).
- You had a procedure to remove the clot (thrombectomy).
- If you are in the target group: the doctor saw a hole in the artery (perforation) with contrast dye leaking out during the procedure.
- If you are in the comparison group: no perforation happened during the procedure.
- You do not have a documented rejection to participate in studies.
- Your imaging before the procedure did not show both a stroke and bleeding in the brain.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two methods for removing blood clots from arteries in the brain during an acute stroke: aspiration (suction) versus stent retriever (a mesh device). The goal is to see which approach works better for patients treated within 24 hours of stroke symptoms.
This trial tests giving a clot-dissolving medicine (rhPro-UK) through a vein before a procedure to remove a large blood clot in the brain. It is for people who had a stroke 4.5 to 24 hours ago and are already scheduled for clot removal. The goal is to see if the medicine helps improve blood flow and outcomes.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This study records outcomes for people having an acute ischemic stroke treated with an endovascular (catheter-based) procedure. It may help doctors understand how clot-removal treatment works in different patients and hospitals.
This trial tests a new catheter (Super-Bore 8/7F) to remove blood clots in people having a major stroke caused by a blocked large artery in the brain. The goal is to see if it is safe and effective at restoring blood flow when used within 24 hours of stroke symptoms starting.
This trial tests a new aspiration catheter (a thin tube that sucks out blood clots) used during an emergency procedure to restore blood flow in the brain after a stroke. It's designed for patients treated within 24 hours of stroke symptoms.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.